GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1 (Q4E123)

Analyse AlphaFold monomer V2.0 prediction for cap-specific mRNA… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
Q4E123
Type
protein
Length
362 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xBeB220F0B5b0C48F46B5DDd3E3b071BC0827f8D6
Molecule
Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1
UniProt
Q4E123
Pockets
1 · best druggability 0.70

Structure

1 distinct chain · 44% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1protein36244% helix, 16% strandQ4E123

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15610.700.7955empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.